Study panning anti-malaria drug Trump took against COVID faces new questions

By Michael Erman NEW YORK (Reuters) - British medical journal the Lancet on Tuesday said it had concerns about data behind an influential article that found hydroxychloroquine increased the risk of death in COVID-19 patients, a conclusion that undercut scientific interest in the medicine championed by U.S. President Donald Trump.

The post Study panning anti-malaria drug Trump took against COVID faces new questions appeared first on Firstpost.

from Firstpost https://ift.tt/3cuxn7e